Washington Trust Advisors’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-745
Closed -$1.38K – 640
2024
Q4
$1.38K Buy
745
+173
+30% +$383 ﹤0.01% 634
2024
Q3
$1.4K Sell
572
-1,152
-67% -$2.58K ﹤0.01% 648
2024
Q2
$3.54K Hold
1,724
– – ﹤0.01% 597
2024
Q1
$4.28K Hold
1,724
– – ﹤0.01% 593
2023
Q4
$4.83K Hold
1,724
– – ﹤0.01% 574
2023
Q3
$4.45K Hold
1,724
– – ﹤0.01% 565
2023
Q2
$5.48K Hold
1,724
– – ﹤0.01% 531
2023
Q1
$4.86K Buy
1,724
+747
+76% +$1.95K ﹤0.01% 614
2022
Q4
$2.66K Sell
977
-750
-43% -$2.19K ﹤0.01% 698
2022
Q3
$5K Sell
1,727
-7,139
-81% -$20.2K ﹤0.01% 702
2022
Q2
$22K Sell
8,866
-648
-7% -$1.85K ﹤0.01% 525
2022
Q1
$31K Hold
9,514
– – ﹤0.01% 514
2021
Q4
$27K Buy
+9,514
New +$27.3K ﹤0.01% 581

Other funds holding ABEV

Washington Trust Advisors's ABEV Position: Q1 2025 in Review

Washington Trust Advisors sold out of Ambev (ABEV) in Q1 2025, closing a stake of 745 shares — an estimated $1.38K sold.

Washington Trust Advisors first reported a position in ABEV in Q4 2021 and held it in 13 quarters. The position peaked at $31K in Q1 2022. 363 funds tracked by Wall St. Rank hold ABEV as of Q1 2025.

  • Washington Trust Advisors reported no remaining Ambev position as of Q1 2025 after selling out during the quarter.
  • Washington Trust Advisors sold 745 Ambev shares in Q1 2025, an estimated $1.38K.
  • Washington Trust Advisors first reported a position in Ambev in Q4 2021 and held it in 13 quarters.
  • Washington Trust Advisors's Ambev position peaked at $31K in Q1 2022.
  • 363 funds tracked by Wall St. Rank held Ambev as of Q1 2025.

Based on Washington Trust Advisors's 13F filing for Q1 2025, filed 25 Apr 2025.